(HealthDay)—The first-ever nonsurgical heart valve to treat patients with severe pulmonary valve regurgitation, often resulting from congenital heart disease, was approved by the U.S. Food and Drug Administration, the agency ...
Mar 30, 2021
0
7
A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the College of Science and Engineering and the Medical School shows for the first time that lab-created heart valves implanted in ...
Mar 17, 2021
0
656
My father is having issues with his aortic valve. He is 53 years old and was told he needs to have a valve replacement. I was reading that there are different types of valves. Can you explain the differences and what option ...
Mar 2, 2021
0
0
New research coming out of UBC's Okanagan campus may take the current 'gold standard' for heart valves to a new level of reliability.
Jan 26, 2021
0
2
Non-degradable prostheses for cardiovascular tissues can be used to replace heart valves and blood vessels, but they can't stay in the body permanently. In two recent papers, TU/e researchers in collaboration with a number ...
Jan 8, 2021
0
74
Options to treat heart valve disease are expanding, allowing patients to avoid surgery when possible, according to a new joint clinical practice guideline from the American College of Cardiology and the American Heart Association. ...
Dec 18, 2020
0
2
Calcific aortic valve disease is not only the most common valve disease in the elderly, it's also the third leading cause of heart disease overall. For those affected, calcium starts to accumulate in their heart valves and ...
Dec 10, 2020
0
131
Stephanie Harris was six months pregnant and in the hospital with excruciating pain. But it wasn't the baby, it was kidney stones.
Dec 8, 2020
0
5
Aortic stenosis is one of the most common heart valve defects. Its prevalence increases with age and it often requires treatment. As well as conventional valve replacement involving open-heart surgery, a less invasive procedure ...
Nov 24, 2020
0
0
The primary results from the RIVER Trial, Rivaroxaban for Valvular Heart disease and Atrial Fibrillation, show that rivaroxaban is comparable to warfarin, which is currently the standard of care anticoagulant prescribed for ...
Nov 16, 2020
0
1
